Recombinant Xenopus tropicalis Partner of Y14 and mago (wibg)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specific delivery times. Proteins ship with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
pym1; pym; wibg; Partner of Y14 and mago; PYM homolog 1 exon junction complex-associated factor; Protein wibg homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-200
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)
Target Names
pym1
Target Protein Sequence
MATPYVTDES GKYIAATQRP DGSWRKQRKV KEGYVPQEEV PVYENKYVKF FKSKPSLPPG LSETDASTGK TQQPSKPDAD TTLSKTAKRN MKRKEKRKQE KGEREQVEDA RQDLERVNIS ETPVQKNLTS AHKNGSASSD NPAAEKAKKI KNLRKKLRQV EELQQKIDSG EIKEPSKEQL EKLSRRKALE EEIEDLELDL
Uniprot No.

Target Background

Function
A key regulator of the exon junction complex (EJC). The EJC is involved in mRNA export, nonsense-mediated decay (NMD), and translation. This protein disassembles the EJC from spliced mRNAs, facilitating translation and inhibiting NMD. Association with the 40S ribosomal subunit restricts its activity to translated mRNAs, preventing premature EJC disassembly.
Database Links

KEGG: xtr:549028

STRING: 8364.ENSXETP00000047260

UniGene: Str.846

Protein Families
Pym family
Subcellular Location
Cytoplasm. Nucleus, nucleolus. Nucleus, nucleoplasm.

Q&A

What is the molecular function of Partner of Y14 and Mago (WIBG/PYM) protein?

Partner of Y14 and Mago (WIBG, also known as PYM) is a key regulator of the Exon Junction Complex (EJC). The EJC is a multiprotein complex that associates immediately upstream of exon-exon junctions on mRNAs following splicing, acting as a positional landmarker for the intron-exon structure of genes. WIBG/PYM functions in directing post-transcriptional processes in the cytoplasm, including mRNA export, nonsense-mediated mRNA decay (NMD), and translation enhancement . WIBG is a cytoplasmic RNA-binding protein that can be excluded from nucleus by Crm1 and interacts with the Mago-Y14 heterodimer through its N-terminal domain .

How conserved is the WIBG/PYM protein across species?

The WIBG/PYM protein structure and function are highly conserved across eukaryotic species. Structural studies have shown that the interaction between PYM and Mago-Y14 is conserved from Schizosaccharomyces pombe to humans (though notably absent in Saccharomyces cerevisiae) . Conservation analysis reveals that the N-terminal domain (approximately residues 1-58) contains the most conserved region of the protein . When comparing human PYM to Drosophila PYM, they share approximately 33% sequence identity, while the components of the Mago-Y14 complex show even higher conservation (88% for Mago, 63% for Y14) .

What is the structural basis for WIBG/PYM interaction with the Mago-Y14 complex?

The crystal structure of the Drosophila ternary complex at 1.9 Å resolution reveals that PYM binds to both Mago and Y14 simultaneously, capping their heterodimerization interface at conserved surface residues . This interaction is mediated by an intricate network between the N-terminal domain of PYM (residues 3-35 in Drosophila) and both components of the Mago-Y14 heterodimer, reinforcing the view that Mago-Y14 functions as a single structural unit . The molecular recognition involves conserved surface residues spanning the entire interaction surface, which explains why this complex formation is conserved across species .

What expression systems are optimal for producing recombinant Xenopus WIBG/PYM protein?

Based on available research, recombinant Xenopus laevis PYM protein has been successfully expressed in yeast expression systems . For other species, such as human WIBG/PYM, Escherichia coli expression systems have been employed . The choice of expression system depends on research requirements for protein folding, post-translational modifications, and yield. For structural studies requiring high purity and yield, E. coli systems may be preferable, while yeast or mammalian expression systems might be more suitable when proper folding and modifications are critical . When designing expression constructs, consideration should be given to including appropriate tags (such as His-tag) for purification purposes .

What purification strategies are most effective for isolating functional WIBG/PYM protein?

Affinity chromatography using tagged recombinant proteins is the predominant strategy for WIBG/PYM purification. His-tagged versions of the protein have been successfully purified to >90% purity . For investigating protein-protein interactions, GST-pull-down assays have proven effective in demonstrating direct binding between WIBG/PYM and the Mago-Y14 complex . When purifying for functional studies, it's important to maintain proper buffer conditions to preserve the RNA-binding capabilities of the protein. The purification strategy should be tailored based on whether the goal is to study WIBG/PYM alone or in complex with Mago-Y14 .

How can researchers investigate the role of WIBG/PYM in nonsense-mediated mRNA decay (NMD)?

To investigate WIBG/PYM's role in NMD, researchers can employ several methodological approaches:

  • Tethering Assays: Human PYM has been shown to be active in NMD tethering assays, where the protein is artificially tethered downstream of a stop codon, resulting in degradation of an NMD reporter . This method can be adapted for Xenopus studies.

  • Mutation Analysis: Structural data has identified residues of Mago that affect NMD when mutated. Researchers can create targeted mutations in the PYM-interacting surface to assess functional impacts on NMD efficiency .

  • Protein-Protein Interaction Studies: Utilize pull-down experiments with recombinant proteins to identify direct interactions between WIBG/PYM and other components of the NMD machinery .

  • Subcellular Localization: Fluorescence microscopy can be used to determine whether WIBG/PYM colocalizes with other NMD factors in cytoplasmic foci, providing insight into its functional context .

What techniques can be employed to study the interaction dynamics between WIBG/PYM and the Mago-Y14 complex?

Several complementary approaches can elucidate the interaction dynamics:

  • Yeast Two-Hybrid Analysis (YTH): This has successfully demonstrated interactions between MAGO and Y14 proteins in various species and can be applied to Xenopus WIBG/PYM studies .

  • Bimolecular Fluorescence Complementation (BiFC) Assays: This technique visualizes protein interactions in living cells and has been employed to confirm MAGO-Y14 interactions .

  • Structural Studies: X-ray crystallography has provided detailed insights into the ternary complex structure at 1.9 Å resolution, revealing precise interaction interfaces .

  • Domain Mapping: Truncation experiments have shown that PYM 1-58 retains Mago-Y14-binding properties, indicating the importance of the N-terminal domain for this interaction .

  • Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC): These biophysical methods can quantify binding affinities and kinetics of WIBG/PYM interactions with the Mago-Y14 complex.

How is WIBG/PYM expression regulated in different tissues of Xenopus?

While specific data for Xenopus tropicalis WIBG/PYM tissue expression is not directly provided in the search results, insights from other species suggest tissue-specific expression patterns. In Hevea brasiliensis, MAGO and Y14 genes (which interact with WIBG/PYM) were expressed in multiple tissues including bark, flower, latex, leaf, and root, with highest transcription levels observed in latex . Expression was also found to be regulated by plant hormones such as ethylene and jasmonate in this species .

For Xenopus studies, researchers could employ the following methods to characterize tissue-specific expression:

  • RT-qPCR: To quantify WIBG/PYM mRNA expression across different tissues and developmental stages.

  • In situ hybridization: To visualize the spatial distribution of WIBG/PYM mRNA in tissue sections.

  • Immunohistochemistry: Using specific antibodies to detect protein localization within tissues.

What is the subcellular localization pattern of WIBG/PYM and how does it relate to function?

WIBG/PYM demonstrates interesting subcellular localization patterns that provide clues to its function. Studies have shown that PYM is predominantly a cytoplasmic RNA-binding protein that is excluded from the nucleus by the export receptor Crm1 . This cytoplasmic localization contrasts with the predominantly nuclear localization of its binding partners Mago and Y14 .

Human PYM accumulates in the nucleoplasm and nucleolus when Crm1-mediated export is inhibited, but notably does not localize to nuclear speckles where Mago-Y14 is typically found . This distinct localization pattern suggests that while PYM might interact with Mago-Y14 in the nucleus under certain conditions, the interaction likely occurs primarily in the cytoplasm as a downstream event .

This subcellular distribution pattern supports a model where WIBG/PYM may function to recognize the Mago-Y14 complex after mRNA export to the cytoplasm, potentially playing a role in the remodeling or disassembly of the exon junction complex during translation or nonsense-mediated decay .

What are common challenges in expressing and purifying functional recombinant WIBG/PYM protein?

Researchers working with recombinant WIBG/PYM may encounter several challenges:

  • Protein Solubility: As an RNA-binding protein with multiple interaction domains, WIBG/PYM may have solubility issues. Optimizing buffer conditions (pH, salt concentration, additives like glycerol) can improve solubility.

  • Protein Stability: The functional integrity of the N-terminal domain is critical for Mago-Y14 binding . Researchers should carefully monitor proteolytic degradation during purification by adding appropriate protease inhibitors.

  • Maintaining RNA-Binding Activity: As WIBG/PYM is an RNA-binding protein, functional assays should verify that recombinant proteins retain this activity.

  • Expression System Selection: Different expression systems (bacterial, yeast, insect, mammalian) may yield proteins with varying degrees of functionality. For instance, while E. coli systems offer high yield, they may lack necessary post-translational modifications .

  • Purification Tag Interference: The location of purification tags (N-terminal vs. C-terminal) may affect protein function, particularly since the N-terminal domain of WIBG/PYM is crucial for Mago-Y14 interaction .

How can researchers verify the functional integrity of purified recombinant WIBG/PYM?

To ensure that purified recombinant WIBG/PYM protein retains functional activity, researchers can employ multiple validation approaches:

  • Protein-Protein Interaction Assays: Pull-down experiments with recombinant Mago-Y14 complex can verify binding capacity . Both GST-pull-down and co-immunoprecipitation approaches have been successfully employed.

  • RNA-Binding Assays: Electrophoretic mobility shift assays (EMSA) or filter-binding assays can assess RNA-binding activity.

  • Structural Analysis: Circular dichroism (CD) spectroscopy can confirm proper protein folding by analyzing secondary structure content.

  • Functional Assays: NMD tethering assays can verify the biological activity of WIBG/PYM in the nonsense-mediated decay pathway .

  • Mass Spectrometry: This can confirm protein identity and detect any post-translational modifications or truncations.

How do Xenopus WIBG/PYM protein characteristics compare to homologs in other model organisms?

The search results provide information about WIBG/PYM from several species that can be compared:

SpeciesSize (amino acids)Key DomainsSubcellular LocalizationInteraction PartnersConservation Level
Xenopus laevis199N-terminal Mago-Y14 binding domainNot specified in resultsMago-Y14High
Drosophila207N-terminal domain (residues 3-35)CytoplasmicMago-Y14Reference
Human203-204Conserved with DrosophilaCytoplasmic, excluded from nucleus by Crm1Mago-Y1433% identity with Drosophila
Hevea brasiliensisNot specifiedNot specifiedPredominantly nuclearHbMAGO and HbY14Not specified

What evolutionary insights can be gained from studying Xenopus WIBG/PYM compared to other vertebrate and invertebrate homologs?

Evolutionary analysis of WIBG/PYM across species reveals:

  • Functional Conservation: The interaction between WIBG/PYM and the Mago-Y14 complex appears to be evolutionarily conserved from Schizosaccharomyces pombe to humans, suggesting fundamental importance in eukaryotic RNA metabolism .

  • Structural Conservation: The N-terminal domain that mediates interaction with Mago-Y14 is the most conserved region of the protein, highlighting its evolutionary significance .

  • Variable C-terminal Regions: While not explicitly detailed in the search results, the fact that truncated versions of PYM (1-58) retain binding activity suggests that C-terminal regions may have evolved more diverse functions across species .

  • Absence in Some Species: WIBG/PYM, along with Mago and Y14, is notably absent from the Saccharomyces cerevisiae genome, suggesting that this pathway evolved after the divergence of different yeast lineages .

Studying Xenopus WIBG/PYM in this evolutionary context could provide insights into the conservation and divergence of post-transcriptional regulatory mechanisms across vertebrates.

What are promising areas for further investigation of WIBG/PYM function in development and disease?

Several promising research directions emerge from current understanding of WIBG/PYM:

  • Developmental Regulation: Given the importance of post-transcriptional regulation in development, investigating WIBG/PYM's role during Xenopus embryogenesis could reveal stage-specific functions in mRNA metabolism.

  • Role in Nonsense-Mediated Decay: Further characterization of WIBG/PYM's specific molecular mechanism in NMD could provide insights into this quality control pathway and its dysregulation in disease .

  • Interaction Network Mapping: Comprehensive identification of WIBG/PYM interaction partners beyond Mago-Y14 could reveal additional functions, as suggested by the interaction between HbMAGO2 and gp91 phox identified in Hevea brasiliensis .

  • Regulation of WIBG/PYM Activity: Investigating post-translational modifications or regulatory mechanisms that control WIBG/PYM function could uncover new layers of control in RNA metabolism.

  • Role in RNA Export and Localization: Further studies on how WIBG/PYM contributes to cytoplasmic RNA fate could elucidate mechanisms of RNA localization and translation regulation.

What novel methodological approaches could advance understanding of WIBG/PYM biology?

Emerging technologies and approaches that could significantly advance WIBG/PYM research include:

  • CRISPR/Cas9 Genome Editing: Generation of Xenopus tropicalis WIBG/PYM knockout or knock-in models to study in vivo function during development.

  • Single-Molecule Imaging: Techniques like single-molecule FISH combined with protein visualization could reveal the dynamics of WIBG/PYM-mediated mRNA regulation in living cells.

  • Cryo-EM Studies: High-resolution structural analysis of larger WIBG/PYM-containing complexes could provide insights into its role in the context of the full exon junction complex or ribosomes.

  • Transcriptome-wide Binding Analysis: CLIP-seq approaches could identify the RNA targets of WIBG/PYM and potentially reveal sequence or structural preferences.

  • Quantitative Proteomics: Mass spectrometry-based approaches could identify dynamic changes in WIBG/PYM interaction partners under different cellular conditions or developmental stages.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.